Researcher, doctoral supervisor, head of the cell gene transformation platform
Affiliated HospitalInstitute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology)
→
Research areas : gene editing, CAR vector design, iPSC, LNP delivery technology; Cutting-edge technologies: CRISPR gene editing CAR cells, GMP construction of lentiviral vectors; Areas of expertise: CAR vector development, gene therapy; Academic highlights: National high-level talent, multiple cell therapy invention patents; Core value: Supporting the research and clinical translation of underlying vector technologies for CAR-T and gene therapy.